RVO is considered a rare condition in patients with APS, and there is an ongoing debate about whether ocular symptoms are directly linked to the presence of aPL and what the best treatment plan should be for these patients [14,15,23]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.